FDA OKs Antibody-Drug Conjugate for Bladder Cancer
Accelerated approval for enfortumab vedotin in post-checkpoint setting
Related Articles
Aluminum in Vaccines Not Culprit in Kids’ Chronic Diseases, Study Shows
Nationwide analysis evaluates autism, asthma, and other disorders in 1.2 million Danish children
Unseen Wounds: Applying Trauma-Informed Approaches in… : AJN The American Journal of Nursing
Using the 4 Rs to create spaces of safety and dignity
Opinion | The ‘Big Beautiful Bill’ Has Thrown a Big Wrench in My Med School Plans
Some of us have had our options limited while others are forced to walk away
Vaping Better for Quitting Cigarettes Than Nicotine Replacement in Tough Population
Randomized trial shows nearly triple the successful quit attempts in adults
Finerenone Gets Expanded FDA Approval in Heart Failure
First nonsteroidal mineralocorticoid receptor antagonist OK’d for higher ejection fractions
Kidney Transplantation Without Lifelong Immunosuppression Edges Toward Reality
Three-fourths of patients off immunosuppression at 2 years with donor-derived cellular therapy
Durable Survival Outcomes in Advanced Melanoma With Neoadjuvant Dual Immunotherapy
Most patients alive and recurrence-free after 4 years of follow-up in phase II trial
GLP-1 Therapy Helps Amplify Bariatric Surgery Weight Loss, but Timing Matters
Using an agent only pre- or postoperatively not different than surgery alone
Youth Emergency Visits for Cannabis Vomiting Disorder Spiked in Recent Years
Rates highest in states with recreational cannabis
Bariatric Surgery No Cure for PCOS in Teen Girls
Few experienced remission of PCOS symptoms despite substantial weight loss